# US 2021/0275245 A1 · Methods of detecting and treating back pain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275245 A1
- Document ID: US20210275245A1
- Status: Published application
- Kind: A1
- Application number: 17/303,267
- Filed: 2021-05-25
- Published: 2021-09-09
- Earliest claimed: 2019-09-12
- Assignees: Relievant Medsystems, Inc.
- Applicants: Relievant Medsystems, Inc.
- Inventors: Brian W. Donovan; Samit Patel; Ray M. Baker; Avram Allan Edidin
- Web page: https://patentgrep.com/patent/US20210275245A1

## CPC

- A61B 17/3423: {Access ports, e.g. toroid shape introducers for instruments or hands (access sites for liquids A61M39/0247)}
- A61N 7/02: Localised ultrasound hyperthermia
- A61B 17/1671: {for the spine}
- A61B 17/3421: {Cannulas}
- A61B 17/3472: {for bones, e.g. intraosseus injections}
- A61B 18/082: {Probes or electrodes therefor}
- A61B 18/1206: {Generators therefor}
- A61B 18/148: {having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy}
- A61B 18/1482: {having a long rigid shaft for accessing the inner body transcutaneously in minimal invasive surgery, e.g. laparoscopy}
- A61B 18/16: Indifferent or passive electrodes for grounding
- A61B 34/20: Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B 34/37: Leader-follower robots (A61B34/35 takes precedence)
- A61B 17/1615: {Drill bits, i.e. rotating tools extending from a handpiece to contact the worked material}
- A61B 17/32053: {Punch like cutting instruments, e.g. using a cylindrical or oval knife (A61B17/326 takes precedence; trepans A61B17/1695)}
- A61B 34/30: Surgical robots
- A61B 2017/00261: {Discectomy}
- A61B 2017/00331: {with preformed bends}
- A61B 2017/00455: {Orientation indicators, e.g. recess on the handle}
- A61B 2017/00477: {Coupling (A61B2017/0046 takes precedence)}
- A61B 2017/1648: {as cutting jet}
- A61B 2018/0044: {Spinal cord}
- A61B 2018/00577: {Ablation}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00714: {Temperature}
- A61B 2018/00732: {Frequency}
- A61B 2018/00738: {Depth, e.g. depth of ablation}
- A61B 2018/00761: {Duration}
- A61B 2018/00791: {Temperature}
- A61B 2018/00815: {measured by a thermistor}
- A61B 2018/00821: {measured by a thermocouple}
- A61B 2018/00875: {Resistance or impedance}
- A61B 2018/00982: {combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes}
- A61B 2018/00994: {combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound}
- A61B 2018/126: {bipolar}
- A61B 2090/0807: {Indication means}
- A61B 2090/374: {NMR or MRI}
- A61N 2007/025: {interstitial}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Described herein are various implementations of systems and methods for accessing and modulating tissue (for example, systems and methods for accessing and ablating nerves or other tissue within or surrounding a vertebral body to treat chronic lower back pain). Assessment of vertebral endplate degeneration or defects (e.g., pre-Modic changes) to facilitate identification of treatment sites and protocols are also provided in several embodiments. Several embodiments comprise the use of biomarkers to confirm or otherwise assess ablation, pain relief, efficacy of treatment, etc. Some embodiments include robotic elements for, as an example, facilitating robotically controlled access, navigation, imaging, and/or treatment.

## Claims

### Claim 1

A method of detecting and treating back pain of a subject, the method comprising:
identifying a candidate vertebral body for treatment based on a determination that the vertebral body exhibits one or more symptoms or defects associated with vertebral endplate degeneration,
wherein the one or more symptoms associated with vertebral endplate degeneration or defects comprise pre-Modic change characteristics; and
ablating a basivertebral nerve within the identified candidate vertebral body by applying a thermal treatment dose to a location within the vertebral body of at least 240 cumulative equivalent minutes (“CEM”) using a CEM at 43 degrees Celsius model.

### Claim 2 (depends on 1)

The method of claim 1,
wherein the determination is based on images of the candidate vertebral body,
wherein the images comprise magnetic resonance imaging images,
wherein the pre-Modic change characteristics comprise characteristics prior to a formal characterization or diagnosis as a Modic change and that exist before painful symptoms manifest themselves to the subject; and
wherein applying the thermal treatment dose comprises delivery of radiofrequency energy using a radiofrequency energy delivery device including a bipolar pair of electrodes, and wherein the radiofrequency energy is continuous and/or pulsed.

### Claim 3 (depends on 2)

The method of claim 2, wherein the determination involves application of one or more filters to the MRI images.

### Claim 4 (depends on 1)

The method of claim 1, wherein the determination is based on obtaining biomarkers from the subject.

### Claim 5 (depends on 3)

The method of claim 3, wherein the biomarkers are obtained from one or more blood serum samples.

### Claim 6 (depends on 3)

The method of claim 3, wherein the biomarkers are obtained over an extended period of time or at a single instance in time.

### Claim 7 (depends on 4)

The method of claim 4, wherein the biomarkers include one or more of: substance P, cytokines, or other compounds associated with inflammatory processes and/or pain.

### Claim 8 (depends on 1)

The method of claim 1, wherein identifying a candidate vertebral body for treatment based on a determination that the vertebral body exhibits one or more symptoms or defects associated with vertebral endplate degeneration comprises determining a quantitative or qualitative endplate score based on severity, extent, and/or quantity of the pre-Modic change characteristics.

### Claim 9 (depends on 1)

The method of claim 1, wherein the pre-Modic change characteristics comprise one or more of: mechanical characteristics, bacterial characteristics, and pathogenetic mechanisms.

### Claim 10 (depends on 1)

The method of claim 1, wherein the pre-Modic change characteristics comprise one or more of: focal defects, erosive defects, rim defects, and corner defects of a vertebral endplate of the vertebral body.

### Claim 11 (depends on 1)

The method of claim 1,
wherein the thermal treatment dose is configured to achieve a target temperature of between 70 degrees Celsius and 90 degrees Celsius;
wherein the thermal treatment dose is delivered with a temperature ramp of between 0.1 and 5 degrees per second,
wherein the thermal treatment does is configured to form a targeted lesion zone having an elliptical shape, a football shape, a disc shape, or a dumbbell shape,
wherein the method is performed without the use of any cooling fluid,
wherein the one or more symptoms or defects are selected from the group consisting of edema, inflammation, damage, tissue changes, and bone marrow lesions within the vertebral body or along a portion of a vertebral endplate of the vertebral body,
wherein applying the thermal treatment dose comprises delivery of one or more of radiofrequency energy, ultrasound energy, microwave energy, and laser energy,
wherein the location within the vertebral body is in a posterior half of the vertebral body or a geometric center of the vertebral body, and/or
wherein the location is at least 5 mm from a posterior border of the vertebral body.

### Claim 12 (depends on 1)

The method of claim 1,
wherein the thermal treatment dose is configured to form a targeted lesion zone having a maximum cross-sectional dimension of less than 15 mm,
wherein the thermal treatment dose is configured to form a targeted lesion zone having a length to width ratio of at least 2:1,
wherein the thermal treatment dose is configured to form a targeted lesion zone having a maximum width of 20 mm and a maximum length of 30 mm, or
wherein the thermal treatment dose is configured to form a targeted lesion zone having a major axis length to minor axis length ratio between 1.5:1 and 3:1.

### Claim 13 (depends on 1)

The method of claim 1, further comprising:
advancing at least a distal end portion of a bipolar radiofrequency energy delivery probe comprising two electrodes to the location;
forming a passageway through a pedicle and into the vertebral body;
then advancing at least the distal end portion of the bipolar radiofrequency energy delivery probe along the passageway to the location; and
applying the thermal treatment dose to the location using the bipolar radiofrequency energy delivery probe.

### Claim 14

A method of detecting and treating back pain of a subject, the method comprising:
obtaining images of a vertebral body of the subject;
analyzing the images to determine whether the vertebral body exhibits one or more symptoms associated with a pre-Modic change,
wherein the one or more symptoms comprise initial indications or precursors of edema or inflammation at a vertebral endplate prior to a formal characterization or diagnosis as a Modic change; and
ablating a basivertebral nerve within the vertebral body if it is determined that the vertebral body exhibits one or more symptoms associated with a pre-Modic change.

### Claim 15 (depends on 14)

The method of claim 14.
wherein ablating the basivertebral nerve within the vertebral body comprises advancing at least a distal end portion of a bipolar radiofrequency energy delivery probe comprising two electrodes to a target treatment location within the vertebral body and applying radiofrequency energy to the location to generate a thermal treatment dose sufficient to ablate the basivertebral nerve,
wherein the radiofrequency energy has a frequency between 400 kHz and 600 kHz,
wherein the thermal treatment dose is configured to achieve a target temperature of between 70 degrees Celsius and 90 degrees Celsius at the location, and
wherein the thermal treatment dose is delivered with a temperature ramp of between 0.1 and 5 degrees Celsius per second.

### Claim 16 (depends on 15)

The method of claim 15,
wherein the radiofrequency energy is applied for an active energy delivery time of between 10 minutes and 20 minutes,
wherein the radiofrequency energy is continuous and/or pulsed,
wherein the temperature ramp is between 0.5 and 3 degrees Celsius per second, and
wherein the thermal treatment does forms a targeted lesion zone having a major diameter along a long axis of between 20 mm and 30 mm and a minor diameter along a short axis of between 5 mm and 15 mm.

### Claim 17 (depends on 14)

The method of claim 14, wherein:
ablating the basivertebral nerve within the vertebral body comprises applying a thermal treatment dose to a location within the vertebral body of at least 240 cumulative equivalent minutes (“CEM”) using a CEM at 43 degrees Celsius model, and
the thermal treatment dose forms a targeted lesion zone at the target treatment location having a maximum cross-sectional dimension of less than 15 mm.

### Claim 18 (depends on 17)

The method of claim 17, wherein applying the thermal treatment dose comprises delivery of one of radiofrequency energy, ultrasound energy, microwave energy, or laser energy

### Claim 19 (depends on 14)

The method of claim 14, wherein the images are obtained using an MRI imaging modality or a CT imaging modality.

### Claim 20 (depends on 14)

The method of claim 14, wherein ablating the basivertebral nerve comprises:
generating a targeted ablation zone having a maximum cross-sectional dimension of less than 15 mm;
generating a targeted ablation zone having a major diameter along a long axis of between 20 mm and 30 mm and a minor diameter along a short axis of between 5 mm and 15 mm,
generating a targeted ablation zone having a length to width ratio of at least 2:1,
generating a targeted ablation zone having a maximum width of 20 mm and a maximum length of 30 mm, or
generating a targeted ablation zone having a major axis length to minor axis length ratio between 1.5:1 and 3:1.
